Cargando…

Treatment options for alcoholic and non-alcoholic fatty liver disease: A review

Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are serious health problems worldwide. These two diseases have similar pathological spectra, ranging from simple steatosis to hepatitis to cirrhosis and hepatocellular carcinoma. Although most people with excessive alcohol o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Sukhpreet, Osna, Natalia A, Kharbanda, Kusum K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643281/ https://www.ncbi.nlm.nih.gov/pubmed/29085205 http://dx.doi.org/10.3748/wjg.v23.i36.6549

Ejemplares similares

Advances in Alcoholic Liver Disease
por: Osna, Natalia, et al.
Publicado: (2012)

Alcoholic Liver Disease: Pathogenesis and Current Management
por: Osna, Natalia A., et al.
Publicado: (2017)

Editorial: Alcohol-associated liver disease—From pathogenesis to treatment
por: Kharbanda, Kusum K., et al.
Publicado: (2022)

Multi-Organ Alcohol-Related Damage: Mechanisms and Treatment
por: Osna, Natalia A., et al.
Publicado: (2016)

Hepatitis C, Innate Immunity and Alcohol: Friends or Foes?
por: Osna, Natalia A., et al.
Publicado: (2015)

A Pathogenic Role of Non-Parenchymal Liver Cells in Alcohol-Associated Liver Disease of Infectious and Non-Infectious Origin
por: Kharbanda, Kusum K., et al.
Publicado: (2023)

Editorial: Cell-to-cell communications in alcohol-associated, metabolic-related and viral liver diseases
por: Osna, Natalia A., et al.
Publicado: (2023)

Role of Elevated Intracellular S-Adenosylhomocysteine in the Pathogenesis of Alcohol-Related Liver Disease
por: Arumugam, Madan Kumar, et al.
Publicado: (2020)

Role of alcohol in pathogenesis of hepatitis B virus infection
por: Ganesan, Murali, et al.
Publicado: (2020)

Pancreatogenic Diabetes: Triggering Effects of Alcohol and HIV
por: New-Aaron, Moses, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
por: Grander, Christoph, et al.
Publicado: (2023)

Alcohol Metabolism Potentiates HIV-Induced Hepatotoxicity: Contribution to End-Stage Liver Disease
por: Ganesan, Murali, et al.
Publicado: (2019)

Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells
por: New-Aaron, Moses, et al.
Publicado: (2020)

Lipidomic Analysis of Liver Lipid Droplets after Chronic Alcohol Consumption with and without Betaine Supplementation
por: Arumugam, Madan Kumar, et al.
Publicado: (2023)

Elevated S-adenosylhomocysteine induces adipocyte dysfunction to promote alcohol-associated liver steatosis
por: Arumugam, Madan Kumar, et al.
Publicado: (2021)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

Contrasting Effects of Fasting on Liver-Adipose Axis in Alcohol-Associated and Non-alcoholic Fatty Liver
por: Rasineni, Karuna, et al.
Publicado: (2021)

Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
por: Tidwell, Jasmine, et al.
Publicado: (2023)

Alcohol-and-HIV-Induced Lysosomal Dysfunction Regulates Extracellular Vesicles Secretion in Vitro and in Liver-Humanized Mice
por: Dagur, Raghubendra Singh, et al.
Publicado: (2021)

Alcohol-Induced Lysosomal Damage and Suppression of Lysosome Biogenesis Contribute to Hepatotoxicity in HIV-Exposed Liver Cells
por: New-Aaron, Moses, et al.
Publicado: (2021)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Treatment of non-alcoholic fatty liver disease
por: Tolman, Keith G, et al.
Publicado: (2007)

Liver as a target of human immunodeficiency virus infection
por: Ganesan, Murali, et al.
Publicado: (2018)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review
por: Głuszyńska, Paulina, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and lipotoxicity
por: Wasilewska, Natalia, et al.
Publicado: (2021)

Cell-to-Cell Communications in Alcohol-Associated Liver Disease
por: Osna, Natalia A., et al.
Publicado: (2022)

Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
por: Ganesan, Murali, et al.
Publicado: (2019)

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
por: Ganguli, Surosree, et al.
Publicado: (2019)

Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology
por: Rasineni, Karuna, et al.
Publicado: (2016)

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
por: Malnick, Stephen D. H., et al.
Publicado: (2022)

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
por: Francque, Sven, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease: An expanded review
por: Benedict, Mark, et al.
Publicado: (2017)

Pathogenesis of non-alcoholic fatty liver disease
por: Dowman, J. K., et al.
Publicado: (2010)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

Lipidomics in non-alcoholic fatty liver disease
por: Kartsoli, Sofia, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
por: Vajro, Pietro, et al.
Publicado: (2012)

The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
por: Oh, Hyunwoo, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Bush, Haley, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o8750o1forkqbneia6f20ogag5